Jefferies Financial Group began coverage of MSCI stock, while Raymond James raised its target price and Morgan Stanley reaffirmed its rating.
4 reports, 2 independent
Updated Sep 5
Gone quiet
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Jefferies Financial Group began coverage of MSCI stock, while Raymond James raised its target price and Morgan Stanley reaffirmed its rating.
Who's involved
What this event is mainly aboutKeep exploring
Part of
Morgan Stanley, MSCI, Raymond James Financial, and Benzinga are involved in the process of receiving and issuing analyst ratings and research reports on company stocks.Also in this story
- Morgan Stanley and Raymond James Financial issued conflicting analyst ratings (raise/downgrade) for V2X, Inc. on August 18, 2026.
- Morgan Stanley raised price targets and ratings for Ultragenyx Pharmaceutical.
The entities involved
-
Jefferies Financial Group
American financial services company
-
MSCI
American financial service provider
-
Raymond James Financial
American Investment Bank and Financial Services Firm
Related events
- Morgan Stanley, Barclays, Jefferies, and Benchmark initiated coverage or raised price targets for International Flavors & Fragrances.
- Jefferies Financial Group raised its price target for Shoals Technologies Group stock.
- Jefferies started coverage with a buy rating on Formula One Group, while MarketBeat provided the average stock rating.
- Jefferies Financial Group started coverage and issued a buy rating on Cameco.
- Truist Financial started coverage on NETSTREIT, while Jefferies Financial Group restated a buy rating.